223 related articles for article (PubMed ID: 33295414)
21. Genetics of Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions.
Blum S; McCombe PA
J Peripher Nerv Syst; 2014 Jun; 19(2):88-103. PubMed ID: 25039604
[TBL] [Abstract][Full Text] [Related]
22. Immune Cell Profiling of the Cerebrospinal Fluid Provides Pathogenetic Insights Into Inflammatory Neuropathies.
Heming M; Schulte-Mecklenbeck A; Brix T; Wolbert J; Ruland T; Klotz L; Meuth SG; Gross CC; Wiendl H; Meyer Zu Hörste G
Front Immunol; 2019; 10():515. PubMed ID: 30984164
[No Abstract] [Full Text] [Related]
23. Virus discovery in chronic inflammatory demyelinating polyneuropathy.
van Lieverloo GGA; Wieske L; van Schaik IN; Deijs M; van der Hoek L; Eftimov F
J Neuroimmunol; 2021 Sep; 358():577668. PubMed ID: 34325344
[TBL] [Abstract][Full Text] [Related]
24. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Kuwahara M; Suzuki S; Takada K; Kusunoki S
J Neuroimmunol; 2011 Oct; 239(1-2):87-90. PubMed ID: 21914557
[TBL] [Abstract][Full Text] [Related]
25. [Immunopathology and treatments of Guillain-Barré syndrome and of chronic inflammatory demyelinating polyneuropathy].
Radziwill AJ; Kuntzer T; Steck AJ
Rev Neurol (Paris); 2002 Mar; 158(3):301-10. PubMed ID: 11976589
[TBL] [Abstract][Full Text] [Related]
26. Novel immunotherapeutic strategies in chronic inflammatory demyelinating polyneuropathy.
Mathis S; Vallat JM; Magy L
Immunotherapy; 2016 Feb; 8(2):165-78. PubMed ID: 26809024
[TBL] [Abstract][Full Text] [Related]
27. Serum cytokine and chemokine profiles in patients with chronic inflammatory demyelinating polyneuropathy.
Beppu M; Sawai S; Misawa S; Sogawa K; Mori M; Ishige T; Satoh M; Nomura F; Kuwabara S
J Neuroimmunol; 2015 Feb; 279():7-10. PubMed ID: 25669993
[TBL] [Abstract][Full Text] [Related]
28. Antecedent infections and vaccinations in chronic inflammatory demyelinating polyneuropathy: A European collaborative study.
Rajabally YA; Peric S; Bozovic I; Loo LK; Kalac A; Palibrk A; Basta I
Muscle Nerve; 2021 Dec; 64(6):657-661. PubMed ID: 34263956
[TBL] [Abstract][Full Text] [Related]
29. Acute-onset chronic inflammatory demyelinating polyneuropathy: An electrodiagnostic study.
Anadani M; Katirji B
Muscle Nerve; 2015 Nov; 52(5):900-5. PubMed ID: 25809534
[TBL] [Abstract][Full Text] [Related]
30. Cystatin C and cathepsin B in CSF from patients with inflammatory neurologic diseases.
Nagai A; Murakawa Y; Terashima M; Shimode K; Umegae N; Takeuchi H; Kobayashi S
Neurology; 2000 Dec; 55(12):1828-32. PubMed ID: 11134381
[TBL] [Abstract][Full Text] [Related]
31. Antibody responses to peptides of peripheral nerve myelin proteins P0 and P2 in patients with inflammatory demyelinating neuropathy.
Inglis HR; Csurhes PA; McCombe PA
J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):419-22. PubMed ID: 17158557
[TBL] [Abstract][Full Text] [Related]
32. Oligoclonal IgG bands in chronic inflammatory polyradiculoneuropathies.
Ruiz M; Puthenparampil M; Campagnolo M; Castellani F; Salvalaggio A; Ruggero S; Toffanin E; Cacciavillani M; Gallo P; Franciotta D; Briani C
J Neurol Neurosurg Psychiatry; 2021 Sep; 92(9):969-974. PubMed ID: 33850000
[TBL] [Abstract][Full Text] [Related]
33. Cerebrospinal Fluid Cytokine Expression Profile in Multiple Sclerosis and Chronic Inflammatory Demyelinating Polyneuropathy.
Bonin S; Zanotta N; Sartori A; Bratina A; Manganotti P; Trevisan G; Comar M
Immunol Invest; 2018 Feb; 47(2):135-145. PubMed ID: 29182448
[TBL] [Abstract][Full Text] [Related]
34. Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy.
Dionne A; Nicolle MW; Hahn AF
Muscle Nerve; 2010 Feb; 41(2):202-7. PubMed ID: 19882646
[TBL] [Abstract][Full Text] [Related]
35. Elevation of Gas6 protein concentration in cerebrospinal fluid of patients with chronic inflammatory demyelinating polyneuropathy (CIDP).
Sainaghi PP; Collimedaglia L; Alciato F; Leone MA; Puta E; Naldi P; Castello L; Monaco F; Avanzi GC
J Neurol Sci; 2008 Jun; 269(1-2):138-42. PubMed ID: 18279894
[TBL] [Abstract][Full Text] [Related]
36. CSF CXCL13 is elevated in patients with CIDP and may reflect higher disease activity.
Miyazawa R; Fujimori J; Atobe Y; Nakashima I
J Neuroimmunol; 2023 Dec; 385():578238. PubMed ID: 37925900
[TBL] [Abstract][Full Text] [Related]
37. Expression of chemokines in cerebrospinal fluid and serum of patients with chronic inflammatory demyelinating polyneuropathy.
Mahad DJ; Howell SJ; Woodroofe MN
J Neurol Neurosurg Psychiatry; 2002 Sep; 73(3):320-3. PubMed ID: 12185171
[TBL] [Abstract][Full Text] [Related]
38. Elevated serum levels of endothelin-1 in patients with chronic inflammatory demyelinating polyneuropathy.
Chang CW; Wu HC; Lyu RK; Lo YS; Chen CM; Ro LS; Chang HS; Huang CC; Liao MF; Wu YR; Kuo HC; Chu CC; Weng YC; Wei PT; Lo AL; Chang KH
Clin Chim Acta; 2018 Jan; 476():49-53. PubMed ID: 29137897
[TBL] [Abstract][Full Text] [Related]
39. Tonic pupils: an unusual autonomic involvement in chronic inflammatory demyelinating polyneuropathy (CIDP).
Escorcio-Bezerra ML; Manzano GM; Bichuetti DB; Nunes KF; Correa DSA; Oliveira ASB; Baeta AM
Neurol Sci; 2019 Aug; 40(8):1725-1727. PubMed ID: 30997592
[TBL] [Abstract][Full Text] [Related]
40. Increased Cerebrospinal Fluid Adenosine 5'-Triphosphate Levels in Patients with Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy.
Nukui T; Niimi H; Hayashi T; Dougu N; Yamamoto M; Shibuya R; Matsuda N; Tanaka R; Hirosawa H; Furuta R; Mitsui T; Maesaka H; Takasawa S; Kitajima I; Nakatsuji Y
Neurol Res Int; 2024; 2024():7229216. PubMed ID: 38887668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
